- Could Americans Get to COVID Herd Immunity by Late Spring?
- Switch to Plant-Based Diet Could Protect Older Women’s Brains
- COVID in Pregnancy Tied to Higher Odds for ‘Preemie’ Delivery
- ‘Night Owls’ Perform Worse at Work, Study Finds
- Pharmacies Will Distribute COVID-19 Vaccines: What You Need to Know
- Coronavirus Antibodies Appear to Stop Reinfection for Months
- AHA News: What’s Safe Once You’ve Had Your COVID-19 Vaccine?
- FDA Review Finds J&J COVID Vaccine Safe, Effective
- Health Highlights: Feb. 24, 2021
- Migraines? Get Moving: Exercise Can Help Curb Attacks
Clinical Trials Update: Aug. 3, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Excessive Daytime Sleepiness
This study of an investigational drug is for people aged 18 to 55 who find it difficult to stay awake during the day.
The research site is in New York City.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/sleep.aspx.
—–
Depression
This study of an investigational drug is for people who take medication for depression but still have symptoms.
The research site is in Denver, Colo.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/depression.aspx.
—–
Menstrual Migraine
This study of an investigational drug is for women who have migraines associated with the menstrual period. Participants will receive study-related care and study drug at no cost, and may be compensated up to $350 for time and travel.
The research site is in San Antonio, Texas.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/migraine.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
